Natural health products good manufacturing practices pre-inspection package
The new natural health products (NHP) good manufacturing practices (GMP) pre-inspection package is for anyone who conducts licensable activities involving NHPs including manufacturers, packagers, labellers and importers....
Changes made to list of non-prescription drugs: Notice of modification
The Regulatory Operations and Enforcement Branch has amended the List of non-prescription drugs for which the testing requirements set out in subsections C.02.019 (1) and (2) of the Food and Drug Regulations...
Notice: Clinical trials for medical devices and drugs relating to COVID-19 regulations
Information on the regulations for clinical trials for medical devices and drugs relating to COVID-19 transition from the Interim Order....
Notice of updated guidance: Applications for COVID-19 drug clinical trials under the Regulations
Health Canada has updated and renamed the guidance document that was created for the interim orders No. 1 and No. 2 for COVID-19-related clinical trials for drugs....
Notice: Period reduced for keeping clinical trial records for drugs and natural health products
Information on Health Canada reducing the period for keeping clinical trial records for drugs and natural health products from 25 years to 15 years....
Notice: Regulations amending certain regulations concerning drugs and medical devices (shortages)
The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were made on 03-02, 2022. They amend the Food and Drug Regulations and Medical Devices Regulations that were published on 09-01-2022. They extend and modify...
What we heard report on the clinical trials regulatory modernization initiative
Health Canada has published a "What we heard" report summarizing the comments received during the consultation on our Clinical Trials Regulatory Modernization Initiative from May 20, 2021 to July 4, 2021....
Guidance Document on the Distribution of Drugs as Samples
Health Canada is pleased to announce the Guidance Document â Distributing samples of prescription drugs, non-prescription drugs and natural health products...
Stop illegal marketing of drugs and devices
Find out about the impacts of illegal marketing, illegal marketing techniques, how to file a marketing complaint, and how we handle the complaints we receiveâ....
Web Posting â New Form for Natural Health Product Licence Applications
The Natural and Non-prescription Health Products Directorate is pleased to announce the posting of the new web-based Natural Health Product Licence Application Form (web PLA form)....
Natural and Non-prescription Health Products Directorate (NNHPD) June 1, 2018 â December 31, 2018 â Engagement and Priorities
The Natural and Non-prescription Health Products Directorate has posted an overview of anticipated priorities and engagement opportunities....
Web Posting â New Form and Accompanying User Guide for Natural Health Product Licence Amendments and Notifications
The Natural and Non-prescription Health Products Directorate is pleased to announce the posting of the new Natural Health Product Licence Amendment and Notification Form (ANF) as well as its accompanying user guide...
Natural Health Products Ingredients Database is experiencing technical difficulties
We are actively working on a solution and apologize for any inconvenience this may cause....
Health Canada Launches Public Consultations on the Proposed Approach to the Regulation of Cannabis
The proposed approach builds on the extensive consultations conducted by the Task Force on Cannabis Legalization and Regulation and on Canadaâs existing system of regulated production of cannabis for medical purposes and industrial hemp....
Web Posting â Revised Monograph (Cognitive Functions Products)
The Natural and Non-prescription Health Products Directorate is announcing the final posting of the revised monograph for Cognitive Function Products....
The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.